[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369538-105":59,"doc-detail-369538-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","scutellarin-suppresses-ovarian-cancer-progression-by-targeting-mettl5-research-aims-and-findings","Scutellarin suppresses ovarian cancer progression by targeting METTL5 - Research aims and findings","","Scutellarin, a natural compound with reported antitumor activity in multiple cancers, is evaluated as a therapy for ovarian cancer and its underlying molecular mechanism. The study tests effects on cell proliferation and migration in ovarian cancer cell lines (SKOV3, A2780, OVCAR3, OVCAR8) and validates findings using patient-derived ovarian cancer organoids with viability, ATP, and histological readouts. METTL5 protein regulation is assessed by western blot, while METTL5 RNA/protein expression and prognostic relevance are analyzed using public cancer databases and Kaplan–Meier tools. Scutellarin markedly suppresses growth, migration, clonogenicity, and organoid activity, and links the elevated METTL5 expression in tumor tissue to poorer outcomes. Rescue experiments confirm that Scutellarin inhibits ovarian cancer migration by targeting METTL5, supporting a novel therapeutic strategy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/scutellarin-suppresses-ovarian-cancer-progression-by-targeting-mettl5-research-aims-and-findings/369538/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/scutellarin-suppresses-ovarian-cancer-progression-by-targeting-mettl5-research-aims-and-findings/369538.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research goal of the study on Scutellarin in ovarian cancer?","Question",{"text":112,"@type":113},"To assess the therapeutic potential of Scutellarin in ovarian cancer and determine its underlying mechanism, focusing on METTL5 as a target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does Scutellarin affect ovarian cancer cells and organoids?",{"text":117,"@type":113},"Scutellarin significantly inhibits proliferation and migration in ovarian cancer cell lines, and in organoid models it reduces growth, induces cellular damage, and decreases ATP levels.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports METTL5 as the mechanism targeted by Scutellarin?",{"text":121,"@type":113},"METTL5 RNA/protein expression is higher in ovarian cancer than normal tissue, and Scutellarin downregulates METTL5 protein; rescue experiments further show that Scutellarin suppresses migration through METTL5 targeting.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369538,1790382617,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nScutellarin suppresses ovarian cancer progression by targeting METTL5  \nLing Ding1,7, Cenxin Luo2,7, Nathaniel Weygant3, Wutao Chen4,5, Dan Ru1, Yi Lai6, You Wang4,5􀀍 & He Li1􀀍  \nScutellarin, a natural compound extracted from Scutellaria barbata, has demonstrated antitumor activity in various cancers. However, its role in ovarian cancer has not been fully explored. This study aims to evaluate the therapeutic potential and underlying mechanisms ofScutellarin in ovarian cancer. The effects of Scutellarin on cell proliferation and migration were assessed in ovarian cancer cell lines including SKOV3, A2780, OVCAR3, and OVCAR8 . Patient-derived ovarian cancer organoids were used to further validate the in vitro findings. Calcein-AM and PI staining were used to analyze cell viability, and ATP assays were performed to assess organoid activity. Western blot was used to evaluate the regulation of METTL5 protein by Scutellarin. The gene and protein expression levels of METTL5 and their association with ovarian cancer prognosis were assessed using the databases The Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis 2 (GEPIA2), TNMplot, KM-plotter and The Cancer Genome Atlas (TCGA). The functional role of METTL5 was assessed by transwell migration and colony formation assays, and its involvement in Scutellarin’s mechanism of action was confirmed by rescue experiments using wound healing and transwell assays. Scutellarin significantly inhibited the proliferation and migration of ovarian cancer cells. In organoid models, Scutellarin markedly reduced organoid growth, induced cell damage, and decreased ATP levels. Compared to normal ovarian tissue, ovarian cancer tissue exhibited elevated RNA and protein expression levels of METTL5 . High METTL5 expression was associated with poorer prognosis in ovarian cancer patients and promoted the migration and clonogenicity of ovarian cancer cells. Scutellarin downregulated METTL5 expression, and rescue experiments demonstrated that Scutellarin inhibited ovarian cancer migration by targeting METTL5. Scutellarin demonstrates potent, broad-spectrum anti-tumor activity in ovarian cancer cell lines, potentially mediated through targeting METTL5. These findings suggest a novel and promising therapeutic strategy for ovarian cancer treatment.  \nKeywords Scutellarin, METTL5, Ovarian cancer, Patient-derived organoids, Anti-cancer therapy  \nOvarian cancer, often diagnosed at an advanced stage due to its asymptomatic nature and anatomical location, exhibits substantial heterogeneity. Epithelial tumors are the most common type, further categorized into high-grade and low-grade serous carcinomas, endometrioid carcinoma, clear cell carcinoma, and mucinous carcinoma, with high-grade serous carcinoma being the most prevalent1. While surgery and chemotherapy are standard treatments, drug resistance, recurrence, and metastasis remain major obstacles. Thus, there is an urgent need for novel therapeutic strategies and further elucidation of the molecular mechanisms driving ovarian cancer progression.  \nScutellarin, a flavonoid compound primarily derived from the extract of Erigeron breviscapus, is known for its anti-inflammatory and antioxidant properties. It exerts neuroprotective effects in ischemic brain injury by inhibiting inflammation and is effective in cardiovascular protection2. Recent studies have further explored the anti-cancer potential of Scutellarin, demonstrating its ability to induce apoptosis, inhibit cell proliferation  \n1Traditional Chinese Medicine Department, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. 2Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China. 3Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.  \n4Department of Obstetrics and Gynecology, Renji Hos","cbCaig8TbqkvgvS5","https://ap.wps.com/l/cbCaig8TbqkvgvS5","pdf",2750977,13,"English","# Scutellarin’s rationale for ovarian cancer therapy\n## Experimental evaluation in cell lines and organoids\n## METTL5 regulation and clinical relevance\n## Functional assays and rescue confirmation\n# METTL5 as a mechanistic target","[{\"question\":\"What is the main research goal of the study on Scutellarin in ovarian cancer?\",\"answer\":\"To assess the therapeutic potential of Scutellarin in ovarian cancer and determine its underlying mechanism, focusing on METTL5 as a target.\"},{\"question\":\"How does Scutellarin affect ovarian cancer cells and organoids?\",\"answer\":\"Scutellarin significantly inhibits proliferation and migration in ovarian cancer cell lines, and in organoid models it reduces growth, induces cellular damage, and decreases ATP levels.\"},{\"question\":\"What evidence supports METTL5 as the mechanism targeted by Scutellarin?\",\"answer\":\"METTL5 RNA/protein expression is higher in ovarian cancer than normal tissue, and Scutellarin downregulates METTL5 protein; rescue experiments further show that Scutellarin suppresses migration through METTL5 targeting.\"}]","Scutellarin suppresses ovarian cancer progression by targeting METTL5 - Research aims and findings | PDF",1790183311,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/392c72ee99cc2d29df174efd060f0577.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f4533b490bbcaba42720cee83b5e4e1.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eb4f35d6fa8bf218abdc584891de738.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8f4395f97d0929dfbc786a352dadff3.webp",980,1287]